Distribution of 10-Year and Lifetime Predicted Risks for Cardiovascular Disease in US Adults: Findings From the National Health and Nutrition Examination Survey 2003 to 2006

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Circulation. Cardiovascular Quality and Outcomes

• Publication date

  2010-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCOUTCOMES.109.869727PMID 20123666PMCID PMC3058791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Health and Nutrition Examination Survey

  2010cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2009cited by this paper
• Prevalence and Progression of Subclinical Atherosclerosis in Younger Adults With Low Short-Term but High Lifetime Estimated Risk For Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults Study and Multi-Ethnic Study of Atherosclerosis

  2009cited by this paper
• Cardiology patient pages. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism.

  2009cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool.

  2008cited by this paper
• Abstract 3666: Remaining Lifetime Risks for Cardiovascular Disease Death by Risk Factor Burden at Selected Ages in Black and White Men and Women

  2007cited by this paper
• Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

  2007cited by this paper
• Framingham risk score and prediction of coronary heart disease death in young men.

  2007cited by this paper
• Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

  2007cited by this paper
• Implications of Cardiac Risk and Low-Density Lipoprotein Cholesterol Distributions in the United States for the Diagnosis and Treatment of Dyslipidemia: Data From National Health and Nutrition Examination Survey 1999 to 2002

  2007cited by this paper
• Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

  2007cited by this paper
• Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry).

  2007cited by this paper
• Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates.

  2007cited by this paper
• Limitations of current cardiovascular disease risk assessment strategies in women.

  2006cited by this paper
• Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age

  2006cited by this paper
• Commentary: Limitations of Current Cardiovascular Disease Risk Assessment Strategies in Women

  2006cited by this paper
• Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia

  2006cited by this paper
• Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia

  2006cited by this paper
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

  2006cited by this paper
• Cardiovascular Risk Factors Predictive for Survival and Morbidity‐Free Survival in the Oldest‐Old Framingham Heart Study Participants

  2005cited by this paper
• Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000.

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000

  2004cited by this paper
• Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

  2004cited by this paper
• Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality.

  2004cited by this paper
• The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.

  2004cited by this paper
• Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study.

  2003cited by this paper
• Favorable cardiovascular risk profile in middle age and health-related quality of life in older age.

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

  2001cited by this paper
• LOW RISK-FACTOR PROFILE AND LONG-TERM CARDIOVASCULAR AND NON-CARDIOVASCULAR MORTALITY AND LIFE EXPECTANCY

  2000cited by this paper
• Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

  1999cited by this paper
• The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer.

  1999cited by this paper
• Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs.

  1998cited by this paper
• Prevention of cardiovascular risk factors in the first place.

  1996cited by this paper
• The decline in coronary heart disease mortality.

  1982cited by this paper
• Reflections on Cardiovascular Diseases

  1978cited by this paper

• Unveiling the Power of Bergamot: Beyond Lipid-Lowering Effects

  2025cites this paper
• Novel Concepts for the Estimation of Lifetime Cardiovascular Risk

  2025cites this paper
• Hypothesis- and data-driven disease risk scores among young adults - An analysis in the German DONALD cohort study.

  2025cites this paper
• The value of pregnancy-related factors in the prediction of cardiovascular disease: a systematic review

  2025cites this paper
• Discordance of 10- and 30-Year Predicted Risk for Cardiovascular Disease in US Adults.

  2025cites this paper
• Evaluating the Real-World Use of Topical Diclofenac Sodium Gel 1% Using US Longitudinal Electronic Health Records Database: A study supporting OTC switch

  2025cites this paper
• Prévention primaire de la maladie athéromateuse – un objectif prioritaire : dépister le haut risque cardiovasculaire

  2024cites this paper
• Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward

  2024cites this paper
• Sympathetic and blood pressure reactivity in young adults with major depressive disorder.

  2024cites this paper
• MSGene: a multistate model using genetic risk and the electronic health record applied to lifetime risk of coronary artery disease

  2024cites this paper
• Breaking the mold: embracing early detection of coronary artery disease by coronary computed tomography angiography and the role of cumulative risk factor exposure.

  2024cites this paper
• Impact of the 2021 ESC Prevention Guideline's stepwise approach for cardiovascular risk factor treatment in patients with established ASCVD.

  2024cites this paper
• Cardiac autonomic function is preserved in young adults with major depressive disorder.

  2024cites this paper
• Determining the Proportionality of Ischemic Stroke Risk Factors to Age

  2023cites this paper
• Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association

  2023cites this paper
• MSGene: Derivation and validation of a multistate model for lifetime risk of coronary artery disease using genetic risk and the electronic health record

  2023cites this paper
• Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term Risk

  2023cites this paper
• Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención primaria de enfermedad cardiovascular en la mujer

  2022cites this paper
• Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults

  2022cites this paper
• Association of Depression With 10-Year and Lifetime Cardiovascular Disease Risk Among US Adults, National Health and Nutrition Examination Survey, 2005–2018

  2022cites this paper
• Major Global Coronary Artery Calcium Guidelines.

  2022cites this paper
• Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement

  2022cites this paper
• A Cohort Analysis of Statin Treatment Patterns Among Small-Sized Primary Care Practices

  2022influential citation
• Age Specific Models to Capture the Change in Risk Factor Contribution by Age to Short Term Primary Ischemic Stroke Risk

  2022cites this paper
• A review of risk concepts and models for predicting the risk of primary stroke

  2022influential citation
• Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop

  2022cites this paper
• Rationale and design of the sirolimus eluting balloon utilization for treatment of vasculogenic erectile dysfunction: the SUASION Registry.

  2022cites this paper
• Psychotic experiences as a health indicator: A provisional framework

  2021cites this paper
• The effects of communicating cardiovascular disease risk as 'fitness age' on behavioral intentions and psychological outcomes.

  2021cites this paper
• Development and Validation of a Long-Term Incident Heart Failure Risk Model

  2021cites this paper
• Comparison of preoperative and postoperative Lipid Profile changes in obese and morbidly obese patients after mini gastric bypass surgery

  2021cites this paper
• Individual differences in habitual short sleep duration and dysfunction: Subjective health versus objective cardiovascular disease risk.

  2021influential citation
• Life‐Course Reproductive History and Cardiovascular Risk Profile in Late Mid‐Life: The CARDIA Study

  2020cites this paper
• Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation)

  2020cites this paper
• Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry)

  2020cites this paper
• Change in predicted 10-year and lifetime cardiovascular disease risk after Roux-en-Y gastric bypass.

  2020cites this paper
• Cardiovascular risk Calculators and their Applicability to South Asians.

  2020cites this paper
• Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

  2020cites this paper
• Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure

  2020cites this paper
• Promoting Cardiovascular Health

  2020cites this paper
• Cardiovascular Risk and Cardiovascular Health Behaviours in the Transition from Childhood to Adulthood.

  2020cites this paper
• Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk

  2020cites this paper
• LDL-C: lower is better for longer—even at low risk

  2020cites this paper
• Heart Failure Risk Distribution and Trends in the United States Population, NHANES 1999-2016.

  2020cites this paper
• Lifetime risk predictions for cardiovascular diseases: Competing risks analyses on a population-based cohort in Sweden.

  2020cites this paper
• The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia

  2020cites this paper
• For Non-HDL Cholesterol, "Lower Is Better" but "Lower for Longer" May Be Best.

  2020cites this paper
• Machine Learning in Cardiology—Ensuring Clinical Impact Lives Up to the Hype

  2020cites this paper
• A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort

  2020cites this paper
• Novel molecular plasma signatures on cardiovascular disease can stratify patients throughout life.

  2020cites this paper
• Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

  2019cites this paper
• Association of Long-Term Risk Factor Levels With Carotid Atherosclerosis: The Chicago Healthy Aging Magnetic Resonance Imaging Plaque Study (CHAMPS).

  2019cites this paper
• The Optimizing-Risk-Communication (OptRisk) randomized trial – impact of decision-aid-based consultation on adherence and perception of cardiovascular risk

  2019cites this paper
• Will Teens Go Red? Low Cardiovascular Disease Awareness Among Young Women

  2019cites this paper
• Identifying and managing younger women at high risk of cardiovascular disease

  2019cites this paper
• Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.

  2019cites this paper
• The Optimizing-risk-communication (Optrisk) randomized trial – impact of decision-aid-based consultation on adherence and perception of cardiovascular risk

  2019cites this paper
• The Optimizing-risk-communication (Optrisk) randomized trial – impact of decision-aid-based consultation on adherence and perception of cardiovascular risk

  2019cites this paper
• Atherosclerosis

  2019cites this paper
• ECONOMIC ASPECTS OF THE HEALTH CONSCIOUSNESS

  2019cites this paper
• Risk assessment to prevent heart failure

  2019cites this paper
• Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.

  2019cites this paper
• Predicting 10-Year and Lifetime Stroke Risk in Chinese Population.

  2019cites this paper
• Identification of six cardiovascular risk biomarkers in the young population: A promising tool for early prevention.

  2019cites this paper
• Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

  2018cites this paper
• Psychotic experiences as indicators of risk for cardiovascular disease.

  2018cites this paper
• Real‐world observational results from a database of 48 million men in the United States: Relationship of cardiovascular disease, diabetes mellitus and depression with age and erectile dysfunction

  2018cites this paper
• Predicted 10-year risk of cardiovascular mortality in the 40 to 69 year old general population without cardiovascular diseases in Germany

  2018cites this paper
• Cardiovascular Health in St. Louis Bosnian-Americans

  2018cites this paper
• Using Cluster Analysis to Identify Subgroups of College Students at Increased Risk for Cardiovascular Disease

  2018cites this paper
• Lipid management in patients with chronic kidney disease

  2018cites this paper
• The effect of a new lifetime-cardiovascular-risk display on patients’ motivation to participate in shared decision-making

  2018cites this paper
• Temporal Effect of Bariatric Surgery on Predicted 10-Year and Lifetime Cardiovascular Risk at 1 Month, 6 Months, and 5 Years Following Surgery: A Pilot Study

  2017cites this paper
• Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study

  2017cites this paper
• Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.

  2017cites this paper
• Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

  2017cites this paper
• Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States

  2017cites this paper
• Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool A Special Report From the American Heart Association and American College of Cardiology

  2017cites this paper
• Stable ischemic heart disease in women: current perspectives

  2017cites this paper
• Cardiometabolic risk among HIV-POSITIVE Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy

  2017cites this paper
• Health management of adult hypertension in the United States: Results from the National Health and Nutrition Examination Survey (NHANES)

  2016cites this paper
• Il trattamento interventistico percutaneo può risolvere la disfunzione erettile vasculogenica

  2016cites this paper
• Erectile Dysfunction.

  2016cites this paper
• Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

  2016cites this paper
• The metabolic syndrome and ED

  2016cites this paper
• Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population

  2016cites this paper
• Risk Prediction: Are We There Yet?

  2016cites this paper
• Cardiovascular Disease Prevention in Women

  2015cites this paper
• Cardiovascular risk factors among college students: Knowledge, perception, and risk assessment

  2015cites this paper
• Risk factor burden and control at the time of admission in patients with acute myocardial infarction: Results from the NCDR.

  2015cites this paper
• How Does Cardiovascular Disease First Present in Women and Men?

  2015cites this paper
• Distribution of Short-Term and Lifetime Predicted Risks of Cardiovascular Diseases in Peruvian Adults

  2015cites this paper
• Clinical guidelines on hyperlipidaemia: recent developments, future challenges and the need for an Australian review.

  2015cites this paper
• Total adult cardiovascular risk in Central America.

  2015cites this paper
• Predicted 10-year risk of developing cardiovascular disease at the state level in the U.S.

  2015cites this paper
• Basic Principles of the Princeton Recommendations

  2015cites this paper
• Cardiovascular Risk Prediction: Fact or Fiction? Treat the Patients at Risk or the Population at Risk?

  2015cites this paper
• Perspectives on Cholesterol Guidelines

  2015cites this paper
• Hypertension in young adults.

  2015cites this paper
• How Does Cardiovascular Disease First Present in Women and Men

  2015cites this paper